In our studies, NG25 is shown to inhibit Dox-induced NF-κB activation and disturb the balance between pro-apoptotic and pro-survival pathways and thus it increased the efficacy of Dox chemotherapy in breast cancer cells. This evidence concerns the gene NFKB1 and breast cancer.